BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15580289)

  • 1. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
    Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
    Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
    Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
    Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
    Hahn MA; Marsh DJ
    Oncogene; 2005 Sep; 24(41):6241-8. PubMed ID: 16116486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical assessment of parafibromin in mouse and human tissues.
    Porzionato A; Macchi V; Barzon L; Masi G; Iacobone M; Parenti A; Palù G; De Caro R
    J Anat; 2006 Dec; 209(6):817-27. PubMed ID: 17118068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.
    Tan MH; Morrison C; Wang P; Yang X; Haven CJ; Zhang C; Zhao P; Tretiakova MS; Korpi-Hyovalti E; Burgess JR; Soo KC; Cheah WK; Cao B; Resau J; Morreau H; Teh BT
    Clin Cancer Res; 2004 Oct; 10(19):6629-37. PubMed ID: 15475453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen.
    Iwata T; Mizusawa N; Taketani Y; Itakura M; Yoshimoto K
    Oncogene; 2007 Sep; 26(42):6176-83. PubMed ID: 17404568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
    Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
    Endocr Relat Cancer; 2007 Jun; 14(2):501-12. PubMed ID: 17639063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism.
    Iacobone M; Barzon L; Porzionato A; Masi G; Macchi V; Marino F; Viel G; Favia G
    Surgery; 2007 Dec; 142(6):984-91; discussion 984-91. PubMed ID: 18063086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.
    Farber LJ; Kort EJ; Wang P; Chen J; Teh BT
    Mol Carcinog; 2010 Mar; 49(3):215-23. PubMed ID: 19908240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parafibromin inhibits cancer cell growth and causes G1 phase arrest.
    Zhang C; Kong D; Tan MH; Pappas DL; Wang PF; Chen J; Farber L; Zhang N; Koo HM; Weinreich M; Williams BO; Teh BT
    Biochem Biophys Res Commun; 2006 Nov; 350(1):17-24. PubMed ID: 16989776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene.
    Zhao J; Yart A; Frigerio S; Perren A; Schraml P; Weisstanner C; Stallmach T; Krek W; Moch H
    Oncogene; 2007 May; 26(23):3440-9. PubMed ID: 17130827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.
    Lin L; Czapiga M; Nini L; Zhang JH; Simonds WF
    Mol Cancer Res; 2007 Feb; 5(2):183-93. PubMed ID: 17314275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
    Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
    Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.
    Kim HK; Oh YL; Kim SH; Lee DY; Kang HC; Lee JI; Jang HW; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
    Head Neck; 2012 Feb; 34(2):201-6. PubMed ID: 21717519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
    Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A
    Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
    Cetani F; Ambrogini E; Viacava P; Pardi E; Fanelli G; Naccarato AG; Borsari S; Lemmi M; Berti P; Miccoli P; Pinchera A; Marcocci C
    Eur J Endocrinol; 2007 May; 156(5):547-54. PubMed ID: 17468190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The parafibromin tumor suppressor protein is part of a human Paf1 complex.
    Rozenblatt-Rosen O; Hughes CM; Nannepaga SJ; Shanmugam KS; Copeland TD; Guszczynski T; Resau JH; Meyerson M
    Mol Cell Biol; 2005 Jan; 25(2):612-20. PubMed ID: 15632063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.